As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Inside One of Healthcare's Most Ambitious Hospital Projects 
Turning Condensate Loss into a Systemwide Steam Efficiency Opportunity
The Leapfrog Group Publishes 2026 Ratings for Hospitals and ASCs
Going Solar with No Upfront Costs
Northwell Health Finds Energy Savings in Steam Systems